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Abstract
Regeneration of atrophied alveolar bone prior to insertion 
of dental implants is a major challenge for oral and maxillo-
facial surgery. It has been reported that Bone Marrow (BM) 
derived Mesenchymal Stromal Cells (MSC) retain thera-
peutic potential for bone regeneration.
In the present study, a preclinical mini-pig model simulating 
the clinical setting was established in order to evaluate the 
efficacy of autologous MSC for mandible regeneration. Un-
der general anaesthesia, BM aspirates were collected from 
tibia of mini-pigs (n = 5) and MSC were isolated, charac-
terized and expanded. At the same time, a narrow alveolar 
ridge was simultaneously created by bilateral extraction of 
two premolar teeth and removal of the buccal bone in order 
to simulate the pathological situation in humans. After ex 
vivo expansion, cells were delivered fresh to the surgical 
operating room and seeded on Biphasic Calcium Phos-
phate (BCP) granules for 1 hour followed by implantation 
into the simulated alveolar defects in one pig. The surgical 
defects were closed with sutures and left to heal for eight 
weeks. A bone biopsy was taken and dental implants were 
placed in the newly formed bone.
The bone biopsy taken during the procedure showed miner-
alized bone containing substantial amount of new bone with 
BCP granules embedded in osteoid tissues and dispersed 
throughout the newly formed bone matrix. The data demon-
strate the osteogenic potential of autologous MSC com-
bined with BCP, providing crucial pre-clinical information 
in a large animal aimed at the reconstruction of resorbed 
alveolar bone. 
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Introduction
Extensive bone loss due to trauma, inflammation or 
ablative tumour surgery may result in large bone de-
fects [1], and reconstruction of these defects remains 
a major clinical challenge. In the mandible, the volume 
of the alveolar ridge may also be reduced to a varying 
degree as a result of congenital malformations, loss of 
teeth or aging.
Replacement of missing teeth with dental implants is 
a well-established clinical procedure, but requires an al-
veolar ridge with a minimum bone width of 6 mm [2,3]. 
If the width is inadequate, augmentation of the existing 
bone volume is required [3].
A common approach today to regenerate an alveo-
lar bone involves the application of a barrier membrane 
to establish a suitable environment for ontogenesis, 
by excluding connective tissue cells from the bone de-
fect. The barrier membrane maintains locally applied 
cells close to the bone defect, favouring contribution(s) 
from adjacent bone osteoprogenitor cells to improve 
bone healing [4]. Other current therapeutic approach-
es include the application of bone grafts (autologous, 
allogeneic, xenogenic), as well as a technique known 
as segmental bone transport. In particular, autologous 
bone grafts have become the “gold standard” for bone 
augmentation since these grafts are osteoconductive, 
osteoinductive and contain osteogenic cells [2,5]. How-
ever, there are drawbacks to this approaches it often 
requires a period of anaesthesia and high number of 
personnel, resulting in increased costs for the surgical 
procedures. Additionally, the quantity of the graft is of-
ten inadequate. Donor site morbidity is also a concern, 
with potentially serious sequela such as infections and 
nerve damage. The risks of bone graft failure, usually 
attributable to incomplete integration or infection, in-
creases with defect size [6,7].
The search for alternative treatments of bone de-
fects has led to the introduction of Tissue Engineering 
(TE) strategy combining biomaterials and Mesenchymal 
Stromal Cells (MSC), as demonstrated in preclinical and 
early clinical studies [8]. Depending on the clinical indi-
cations, different biomaterials may be used as scaffolds 
for MSC in bone tissue engineering. Moreover, synthet-
ic bone substitutes, such as Hydroxy Apatite (HA) and 
beta-Tricalcium Phosphate (β-TCP) are safe, bioactive 
and osteoconductive [9]. Several studies have demon-
strated the bioactivity of ceramic materials combining 
HA and Biphasic Calcium Phosphate (BCP) in varying 
proportions [1,10,11]. Furthermore, the feasibility and 
efficacy of combining BCP materials and MSC for bone 
regeneration have been demonstrated in experimental 
animal models [11-13]. However, for a solid translation 
of bone tissue engineering from bench to bedside, pre-
clinical testing in large animals is mandatory to ensure 
suitability and safety for patients. Porcine models are 
widely applied in regenerative medicine studies, using 
cells harvested from numerous sites, including bone 
marrow and adipose tissue. Since mini-pigs have ge-
netic characteristics, gross anatomy, physiology, bone 
healing patterns and chewing apparatus comparable to 
those of humans [14], they are increasingly being used 
to study oral, maxillary and dental procedures [15,16]. 
We therefore designed a study in mini-pigs to simulate 
the clinical conditions for the reconstruction of resorbed 
alveolar bone by using autologous culture expanded 
MSC associated to BCP granules and covered with a tita-
nium reinforced Polytetrafluoroethylene (PTFE) barrier 
membrane. This study aimed at optimizing protocols for 
ex-vivo autologous MSC handling, testing surgical pro-
cedures and evaluating efficacy of this bone tissue engi-
neering approach in a large animal model using critical 
sized defects in the alveolar bone.
Material and Methods
Bone marrow harvest
The animal experiment was performed according to 
the Directive 86/609/EEC on the protection of animals 
used for scientific purposes and conducted at the Cen-
tro di Ricerche ed Applicazioni Biotecnologiche in Chi-
rurgia Cardiovascolare, (CRABCC; Rivolta D`Adda, Italy) 
under the supervision of experienced veterinarians. The 
preclinical trial was approved by the national competent 
authority in April 2012 under the Italian past legislative 
decree D.Lgs 116/92 under the Directive 2010/63/EU. 
The experimental animals were adult female Yucatan 
mini-pigs (n = 6), 16-18 months old with average weight 
60 kilograms. For general anaesthesia, a combination of 
ketamine and midazolam was used intramuscularly, at 
doses of 10 mg/kg and 1 mg/kg respectively, followed 
by administration of a mixture of oxygen and isoflurane 
via facemask and orotracheal intubation. Under general 
anaesthesia, the tibia was disinfected and using sterile 
technique 4 ml of Bone Marrow (BM) was aspirated by 
puncture of the proximal tibia with a 19 or 16 gauge 
syringe (Matek, Georgia, USA). To help prevent coagu-
lation, heparin (Sigma-Aldrich, St. Louis, USA) (500 µL) 
was added to a final concentration of 130 IU/mL.
Porcine MSC culture and expansion
BM samples from the mini-pigs were gently agitat-
ed during transportation at 4 °C to the cell culture lab-
oratory. As an initial step towards porcine MSC (pMSC) 
isolation, an equal volume of Phosphate Buffered Saline 
(PBS) (Merck-Millipore, Germany) was added to the BM 
sample (1:1) followed by mixing twenty times by aspi-
ration through a 19G needle. Red blood cells were then 
lysed for 5 minutes with gentle agitation at 37 °C using 
a 2:1 v/v ratio of sterile filtered lysis buffer consisting of 
8.56 g ammonium chloride (NH
4
Cl), 1 g potassium bicar-
bonate (KHCO
3
), 0.037 g EDTA, dissolved in 1 L ddH
2
O 
(all from Sigma-Aldrich). The marrow solution was cen-
trifuged at 1200 rpm for ten minutes at 37 °C and the 
cells were re-suspended in cell culture medium consist-
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ing of alpha-MEM + 10% defined FBS (Stem cell Tech-
nologies, Vancouver, Canada). Viable cells were count-
ed using 0.4% trypan blue dye exclusion. The cells were 
seeded at 1 × 106 cells/cm2 in T75 culture flasks (Greiner 
Bio-One GmbH, Frickenhausen, Germany) and medium 
was replaced every 4 days of culture in a 37 °C, 5% CO
2
 
humidified incubator (Thermo Scientific, Massachusetts, 
Stati Uniti). Nine days after seeding, the number of colo-
nies formed was determined by counting Colony Form-
ing Unit-Fibroblasts (CFU-F), quantified relative to the 
number of cells initially seeded from the isolated BM, 
according to the formula: (number of colonies/number 
of cells seeded) × 100. The CFU-F were then detached 
for cell expansion by incubation with Trypsin 1X (0.5 mg/
ml) and EDTA 1X (0.22 mg/ml) (Euro clone Spa, Milan, 
Italy) at 37 °C for 7 minutes; for subsequent passage of 
confluent flasks the cells were detached using Trypsin 
10X (Euroclone) at 37 °C for 4 minutes, reseeding cells at 
10 × 103/cm2 in 15 mL culture medium per T75 flask. Cu-
mulative population doublings during the early critical 
phase of expansion within the first four passages were 
calculated by counting the viable trypsinized cells using 
trypan blue dye exclusion, and calculating the number of 
Population Doubling Levels (PDL) according to the formula: 
PD = log (N/N0)/log2, where N0 is the seeded cell number 
and N the harvested cell number [17], (Figure 1).
Porcine MSC immuno phenotyping
Culture expanded pBM-MSC samples were aliquot-
ed in Fluorescence-Activated Cell Sorting (FACS) analysis 
polypropylene tubes (0.5-1 × 106/tube) (Greiner Bio-
One GmbH, Frickenhausen, Germany) for immuno phe-
notype analysis. pBM-MSC were subsequently incubat-
ed in the blocking buffer (100 µl each 0.5-1 × 106 cells) 
containing DMEM (Gibco, Paisley, UK), 10% fetal bovine 
serum (Hyclone, Logan, USA), 0.1 M Sodium Azide and 
human immunoglobulin G (Sigma-Aldrich, Milan, Italy) 
and incubated for 20’ on ice. pBM-MSC were washed in 
PBS (Euroclone, Milan, Italy) and then stained in ice for 
30’ with the follow anti-human monoclonal antibodies: 
CD45 FITC and CD14 APC (Becton Dickinson, Franklin 
Lakes, NJ, USA), CD44 FITC and CD31 PE (ebioscience, 
San Diego, USA), CD29 APC (Biolegend, London, UK), 
CD90 PE, CD105 FITC and CD73 PE (BD Pharmingen, San 
Diego, USA). The pBM-MSC were analysed by FACSARIA 
equipped with Cell Quest software (Becton Dickinson) 
and 10,000 events were acquired.
Porcine MSC multipotency
pBM-MSC were tested for their ability to differentiate 
into the main mesodermal lineages (adipogenic and os-
teogenic) as previously described [17]. Briefly, pBM-MSC 
were induced into adipogenic lineage by culturing in 
DMEM (Gibco) with addition of 1% P/S (Gibco, New York, 
USA), 10% rabbit serum (Euroclone) and 5% horse serum 
(Hyclone) supplemented with dexamethasone (1 µM), 
indomethacin (60 µM), Rh-insulin (10 µM) and isobutyl-
methylxanthine (0.5 mM; all from Sigma). The cells were 
maintained in differentiation media for 10 days and vi-
sualization of adipocyte differentiation was performed 
with of Oil Red O (Sigma-Aldrich, Milan, Italy).
The pMSC osteogenic differentiation potential was 
measured by treating cell cultures with osteogenic induc-
tion medium and subsequently measuring matrix miner-
alization. Briefly, cells were seeded at 1 × 104 cell/cm2 per 
well of a 24-multiwell plate. At 60-70% confluence the cells 
were treated for 10 days with osteogenic induction medi-
um consisting of expansion medium supplemented with 
10 mM β-glycerophosphate, 0.1 mM ascorbic acid-2-phos-
phate, 10 nM Dexamethasone (all from Sigma-Aldrich) 
and 100 ng/ml recombinant bone morphogenetic protein 
(rBMP-2, Peprotech, London, UK). Differentiation towards 
an osteoblastic phenotype was determined based on de-
tection of extracellular matrix mineralization, using a mod-
ified Von Kossa method to stain deposits of organic calcium 
salt [18]. Cultures were fixed in 100% methanol on ice for 2 
minutes and then incubated with 0.1% silver nitrate in de-
ionized water for 3 hours under a 30 W UV lamp. A final set 
of 3 washes of 1 minute each removed non-specific nitrate 
precipitates. Digitally recorded images of at least ten fields 
of view per independently isolated MSC population (n = 3) 
were analysed by Image software (National Institutes of 
Health, USA) to selectively quantify dark positive stained 
areas of organic calcium deposits.
Shipment of pMSC and their attachment to bioma-
terial














5 days Passage 17 days
Figure 1: Phase contrast microscopy of pMSC adherent cells 5 or 7 days after seeding and after first passage show consistent 
cells with a fusiform morphology typical of mesenchymal stromal cells that readily expanded with a relatively constant population 
doubling rate for the first three passages in monolayer culture.
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tained in 20 ml air-free syringes containing Phosphate 
Buffered Saline (PBS) at a density of 20 × 106 cells/ml at 
4 °C for up to 26 hours to simulate and validate the ship-
ping procedure and condition.
Transportation buffer of 8 × 105 pMSC / 100 µL were 
mixed with twenty 1-2 mm diameter granules (≈ 20 
mg) made of 20% Hydroxyapatite and 80% β-Tricalci-
um Phosphate (HA/β-TCP) (Macro/microporous Bipha-
sic Calcium Phosphate, MBCP+ granules, Biomatlante, 
France) in a vertically orientated 1 mL syringes (n = 3). 
The cells were incubated and allowed to attach to the 
granules for 1 hour at room temperature. The scaffold 
granules were treated with 0.4% crystal violet to stain 
the adherent cells and examined under a microscope. 
An image-based histological attachment score was used 
to assess the relative surface area of the scaffold bioma-
terial covered by pMSC [19].
Surgical procedures
Under general anaesthesia narrow alveolar ridges 
were made on the mandibles in one of the animals by 
bilateral extraction of two premolar teeth and removal 
of the buccal bone as a split mouth model (Figure 2). 
The incisions were sutured using monofilament, non-re-
sorbable suture of polypropylene and allowed to heal 
for two months. During surgery, a solution of the anti-
biotic enrofloxacin (5 mg/ml) (Bayer HealthCare LLC, 
Animal Health Division, Pittsburgh, USA) was adminis-
tered IM, followed by Amoxicillin long acting (10 mg/
kg), (Clamoxyl L.A. 250 ML Zoetis, Pfizer) IM for 10 days 
postoperatively. After extubation the pig was returned 
to the enclosure and confined for the first postopera-
tive week. As a prophylactic analgesic, meloxicam, 0.4 
mg/Kg (Metacam Injection 20 mg/ml 100 ml Boehringer 
Ingelheim) was administered intramuscularly, followed 
by IM administration of meloxicam, 0.4 mg/Kg (Meta-
cam Injection 20 mg/ml 100 ml, Boehringer Ingelheim) 
for 7 days after surgery.
After healing for two months, under general anaes-
thesia the alveolar ridge was inspected and the sites 
were re-entered from the canine and distally to the first 
molar (Figure 3). The cortical bone on both sides was 
punctured and 2 tenting mini screws were inserted. Au-
tologous cultured expanded pMSC were mixed with the 
MBCP granules and cells allowed to attach to the gran-
ules for 1 hour and then grafted into the test site. A dose 
of 50 × 106 pMSC suspended in 2.5 ml of physiological 
saline was mixed with 2.5 cm3 of BCP granules of 1-2 mm 
in size packaged in a syringe using a double Luer lock. 
Biomaterial without MSC was placed on the contra lat-
eral site in this split mouth model and used as a control 
site. Dense PTFE titanium reinforced membranes were 
stabilized over the grafts (Figure 4) by pins to the lingual 
and buccal sides (Cytoplast® PTFE titanium reinforced 
membrane and Profix® pins and screws, OSTEOGENIC 
BIOMEDICAL®, USA). For total closure of the wound, the 
Figure 2: Creation of narrow alveolar bone defects; 2 premolars were extracted and the buccal bone were removed to 
simulate an strophied alveolar ridge.
ISSN: 2469-570XDOI: 10.23937/2469-570X/1410050
Gjerde et al. Int J Stem Cell Res Ther 2017, 4:050 • Page 5 of 11 •
terfly®, Italy). At the test site, 2 dental implants (Nobel 
Biocare®, Switzerland) were installed and tested for sta-
bility (Osstell® ISQ; Osstell, Goteborg, Sweden).
Histology
After fixation in neutral formaldehyde 10%, the biop-
sies were processed for non-decalcified histology using 
Polymethyl Methacrylate (PMMA) resin. The biopsies were 
then dehydrated by using ascending concentrations of eth-
mucoperiosteum was stabilised with mattress and single 
sutures. During surgery and postoperatively, antibiotics 
and analgesics were administered as described above. 
After 10 days, the sutures were removed uneventfully, 
under sedation. The pig was kept on a soft diet for the 
remaining experimental period.
After further 60 days of healing the pig was deeply 
anaesthetised and sacrificed. Bone biopsies were taken 
from test and control sites using a trephine burr (But-
Figure 3: Mandibular alveolar ridge, 2 months of healing after creation of the narrow bone defects and before augmentation. 
Arrow pointing at the line indicating the width of the ridge.
Figure 4: The mixture of stromal cells and MBCP+ in place under the membrane. Arrow points to the mixture of granules and 
pMSC.
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scope (NDP view software, Hamamatsu Corp. Japan). For 
SEM observations, blocks were polished using Si C paper 
and cleaned. Contiguous photographs of the blocks were 
made at magnification X50 by using the Back Scattered 
Electron Mode (BSEM), Hitachi, Tabletop TM3000). On 
these SEM images, calcium phosphate granules appeared 
grey/white, mineralized bone in grey and fibrous tissue in 
black.
Statistics
A two-tail Student’s t-test (assuming equal varianc-
es) was used to determine the statistical significance of 
the differences in the dark positive stained areas of or-
ganic calcium deposits. P-Values < 0.05 were considered 
statistically significant.
Results
Isolation, culture and expansion of autologous Yu-
catan mini-pig MSC ex vivo
The harvest volume of less than 6 mL of porcine BM 
tissue yielded approximately 3.15 × 105 ± 9 × 103 cells/mL 
after red blood cell lysis. Of note, in 2 out of 5 harvests, 
the procedure had to be interrupted due to clotting of 
the harvested BM cell suspension despite the anti-clot-
ting agent introduced. The issue was solved by repeat-
anol baths at 4 °C (70%, 80%, 95% and 100% ethanol) and 
finally by soaking for 48 hours in acetone. The biopsies were 
then impregnated with a mixture of 90/10 vol. of meth-
yl methacrylate (Sigma-Aldrich) and Poly-Ethylene Glycol 
400 (PEG, Fluka) for 48 hours at -20 °C under vacuum in 
order to avoid bubbles during polymerization. Finally, the 
biopsies were embedded in PMMA at -20 °C under vacuum 
using an initiator (0.8 wt. % benzoyl peroxide, Merck) and 
propagator (60 µl/5 ml of 1 ml N, N-dimethyl aniline/19 ml 
propanol-2) of radical polymerization. The blocks were cut 
medially in two parts: One part was used to perform a de-
scriptive analysis of the augmented volume, while the sec-
ond part served for Scanning Electron Microscopy (SEM, 
Hitachi, TM3000, Japan) and subsequent quantitative anal-
yses of newly formed bone and the remaining biomaterial. 
A circular inner lock diamond saw (LeicaSP1600, Germany) 
and a grinder/polisher (Bluewher Metaserv 250, Germany) 
were used to prepare 30 µm thick sections mounted on 
polycarbonate slides using epoxy glue. The sections were 
stained using methylene blue (1%) for 90 s and basic fuchsin 
(0.3%) for 25 seconds. This staining revealed mineralized 
bone tissue in purple pink while non-calcified soft tissues 
remain blue purple, and nuclei are stained blue. Histology 
sections were finally scanned (NanoZoomer 2.0RS, Ham-
amatsu Corp. Japan) and observed using a virtual micro-
Figure 5: A,B) Flowcytometry analysis of pBM-MSC surface makers expression. The histogram indicates the negative and 
positive stained cells.
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MSC adhesion to 3D scaffolds after cell transpor-
tation
Using a cell number to scaffold weight ratio con-
sistent with that envisaged for clinical situations, the 
ability of freshly harvested pMSC to adhere to the 3D 
HA-βTCP scaffolds was significantly greater than that of 
pMSC after shipping at high cell density in a saline trans-
port buffer at 4 °C. Nonetheless, although reduced, the 
adhesion potential of pMSC after exposure to shipping 
conditions was > 70% of that exhibited by the control 
cells not exposed to shipping conditions, which would 
be adequate for graft preparation (Figure 7).
Autologous pMSC with BCP granules generate 
abundant bone formation in vivo
In one mini-pig, a critical sized split mouth model 
was used in a pilot study to investigate the efficacy of 
autologous pMSC combined with the MBCP+ ceramic 
material. During the experimental period the animal re-
mained in good health and there were no wound heal-
ing complications or any signs of infection. Two months 
after the mandibular graft, biopsies were taken with tre-
phine burs prior to implant insertion to evaluate new 
bone formation within the defect sites. As shown in Fig-
ure 8, abundant formation of bone tissue was observed 
around the MBCP+ granules at the test site.
Further SEM observations corroborated the histo-
logical analyses (Figure 9). In biopsies of the control site 
without cells, a limited quantity of mineralized bone 
(grey) had formed around the MBCP+ granules (white). 
In contrast, abundant newly formed bone was observed 
in biopsies of the test site with pMSC combined with 
MBCP+ granules.
ing the harvest and maintaining the freshly harvested 
samples in constant agitation using a Biotech Macs mix 
Tube Rotator (Miltenyi, Germany) at +4 °C. After 10 days 
of culture, there was an average of 6.43 ± 1.2 CFU-F/
million seeded cells. Cells were spindle-shape adherent 
cells that readily proliferated in culture, similar to their 
human counterparts. Once detached cells were prolifer-
ating with a cumulative PD of 4.22 ± 0.45 at passage 4.
Porcine MSC characterization and multipotency
In order to characterize cells isolated from pig bone 
marrow, we performed immuno phenotype analysis 
with the follow anti-human monoclonal antibodies: 
CD45, CD14, CD31, CD44, CD29, CD90, CD105 and CD73. 
As seen on Figure 5A (dot plot on right in upper panel) 
cells display physical parameter typical of stromal cells 
population, being negative for CD45, CD14 and CD31 
(Figure 5B bottom panel) and positive for CD44 (99.60 
± 0.20), CD29 (98.95 ± 0.05) and CD90 (98.35 ± 0.45). 
CD73 and CD105 were not been detected confirming 
the results previously obtained from Noort, et al. [20] 
that distinguish these cells from human marrow MSC.
Multi lineage potentials of isolated pMSC was as-
sessed at Passage 4 (P4) inducing differentiation to-
wards osteogenic and adipogenic. The cells were able 
to generate round lipid droplets appearance inside the 
cells and Oil Red O staining confirmed the adipose com-
mitment (Figure 6A). The response of pMSC monolayer 
cultures to osteogenic medium included the formation 
of dense multicellular foci with an extracellular matrix 
that was subsequently stained black by the Von Kossa 
stain for organic calcium salts. Typically, about 6% of 
the monolayer surface was strongly Von Kossa positive, 



















Figure 6: A) Adipogenic differentiation of pBM-MSC by Oil-Red-O (Sigma) after 10 days. Micropictures at magnification 
20X were acquired with invert optic Observer (Zeiss, Munic, Germany) equipped with Axiovison 4.2.2 software (Zeiss); B) 
Photomicrographs of Von Kossa stained cell monolayers showed that in contrast to control pMSC, cells induced by BMP-2 
treatment had significantly more black stained areas (> 5-fold, *p < 0.05) indicative of ex vivo mineralization.
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harvested from mini-pigs could be used to develop a 
large-animal model of a tissue engineering approach to 
mandible regeneration. This preclinical model confirms 
the adipogenic and osteogenic potential of pMSC in vi-
tro. Further, it shows that ex vivo expanded pMSC can 
adequately survive at high cell density under shipment 
conditions consistent with our previous data in humans 
[19]. In addition, the results show that after shipment, 
mini-pig MSC are fully capable of adhesion to the 3D 
scaffold biomaterial within a one-hour time frame, 
thereby meeting the requirements for delivery of cells 
to a surgical team in a surgical operating room.
Based on the literature on reconstruction of alveo-
lar ridges in the atrophied lower jaw, the consensus has 
been that reconstruction here is more difficult because 
The membrane in the test side with the pMSC re-
mained intact under the mucosa (Figure 10). At the 
control site, the membrane was exposed and no healing 
had occurred. A substantial amount of bone is seen un-
der the membrane (Figure 11). In this context, new bone 
had formed in between and in contact with the MBCP+ 
granules.
Discussion
The main finding in this study is that the combina-
tion of autologous pMSC and biomaterial was used suc-
cessfully to augment the alveolar ridge in the mini-pig. 
To the best of the author’s knowledge similar results 
has not been published before. The present study was 
performed to assess whether procedures for isolation 










Figure 7: Phase contrast photomicrographs of blue stained cells adhering to the 3D surface of the HA/β-TCP scaffold. In 
contrast to promptly used control cells, the 3D attachment-index after shipment was significantly reduced (*p < 0.05), but still 
over 70% of the control value. Bar = 100 μm.
Figure 8: Evaluation of newly formed bone in response to MSC/biomaterial graft. A representative histological sample stained 
with methylene blue (1%) and basic fuchsin (0.3%).
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Figure 9: Microgrpahs from a scanning electron microscope, the blocks were made at magnification X50. On these images, 
calcium phosphate granules appeared grey/white, mineralized bone in grey and fibrous tissue in black.
Figure 10: Bone and soft tissue healing after 8 weeks. Control side on left where the membrane is exposed, on the right test 
side a favorable healing outcome is shown.
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lenging, also for the high tendency of BM aspirate to clot, 
despite the anti-clotting agents used. In humans, the ili-
ac crest is a common site for collection of bone marrow. 
However, the bone structure of swine is massive and the 
cortical thicknesses are generally much greater than in 
other species and in humans. Similar problems are en-
countered with collection of BM from the sternum, ex-
cept in neonatal swine. Consequently, in mini-pigs the 
tibia has been considered the easiest site from which to 
obtain BM samples as a logical extension of current sur-
gical procedures. However, despite the central role of 
the porcine model in continued medical advances in the 
field, only limited information is available about porcine 
bone marrow MSC.
Conclusions
The results of this study show that pMSC are capable 
of generating bone, and that this new bone integrated 
with the surfaces of the recipient bone as well as with 
the BCP and re-established the volume of the alveolar 
ridge. However, as these promising results are based on 
observations from a single animal only, further investi-
gation is warranted.
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of limited blood supply, extensive chewing force and 
lack of compliance by the pig with respect to soft diet 
and oral hygiene [21]. In a similar mini-pig trial using 
a bone graft to reconstruct the mandibular ridge, the 
authors did not recommend the intraoral approach be-
cause of complications in healing of the gingival wound 
[22]. The posterior mandible in particular is the most 
difficult area to reconstruct because of limited blood 
supply and the high proportion of cortical bone [2,23]. 
Further, as the oral cavity harbours a relevant microbi-
ological burden, the risk of post-operative infection is 
thought to be high. While limited to a single animal, the 
MSC-augmented area in the mini-pig mandible in the 
present study showed complete remodelling of the de-
fect, a result that exceeded original expectations. The 
data also demonstrated that using only BCP granules as 
bone substitute might not be enough to induce bone 
formation on severely atrophied mandibular bone.
Because of the physiological similarities, translation 
of the results from pigs to humans is more relevant than 
from other experimental animals such as mice and rab-
bits [14]. Indeed, the pig is an established animal model 
for dental, oral, and maxillofacial research and preclin-
ical testing, including novel implant design testing [15], 
since porcine bone anatomy, morphology, healing and 
remodelling are similar to those of humans. In partic-
ular, bone regeneration in humans is 1.0-1.5 mm/day 
with the reported rate for pigs (1.2-1.5 mm/day) being 
closer than that for dogs (1.5-2.0 mm/day) [16].
Harvesting of BM-MSC in the mini-pig has been chal-
Figure 11: Bone healing on the test site where a combination of MSC and biomaterial were used. The granules are still 
visible, but the newly formed bone is shown.
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